Q-omics provides the consensus-scored RNU6-166P profile across patient tissues and cancer cell-line models. RNU6-166P expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RNU6-166P RNA expression shows 4,039 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BLCA, and STAD as cancer lineages where RNU6-166P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-166P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-166P survival associations across molecular data types. RNU6-166P RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-166P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	BLCA (144)	view →

This table ranks reproducible RNU6-166P RNA expression–survival associations across cancer types. High RNU6-166P expression shows unfavorable associations in BLCA, THCA, OV, HNSC and GBM, but favorable associations in STAD. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RNU6-166P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.119	0.722	<.001	144	view →
STAD	DFS	Tertile	III,IV	0.869	0.320	.005	60	view →
THCA	DFS	Tertile	All	0.062	0.811	<.001	36	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
HNSC	OS	Tertile	All	0.352	0.771	.004	24	view →
GBM	OS	Tertile	All	0.020	0.416	<.001	18	view →

Pink = unfavorable, green = favorable. all 8 lineages →

RNU6-166P-BLCA (OS)

Kaplan–Meier survival curve for RNU6-166P RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-166P in patient tissues and cancer cell lines. In patient samples, RNU6-166P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	4,039	STAD (3693)	view →
RNA	3,942	COAD (2255)	view →